Lodestone Wealth Management’s Capital Group Core Bond ETF CGCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.33M Buy
93,309
+10,092
+12% +$260K 0.78% 36
2026
Q2
$2.18M Sell
83,217
-7,893
-9% -$207K 0.77% 36
2026
Q1
$2.39M Buy
91,110
+495
+0.5% +$13.1K 0.95% 32
2025
Q4
$2.4M Buy
90,615
+2,180
+2% +$58.1K 0.98% 30
2025
Q3
$2.35M Buy
88,435
+1,362
+2% +$35.9K 1.06% 31
2025
Q2
$2.29M Sell
87,073
-425
-0.5% -$11.1K 1.12% 29
2025
Q1
$2.3M Buy
87,498
+7,883
+10% +$205K 1.22% 24
2024
Q4
$2.05M Buy
79,615
+15,117
+23% +$397K 1.03% 36
2024
Q3
$1.74M Buy
64,498
+14,845
+30% +$395K 0.87% 43
2024
Q2
$1.28M Buy
49,653
+14,978
+43% +$385K 0.68% 54
2024
Q1
$901K Buy
+34,675
New +$904K 0.47% 64

Other funds holding CGCB

Lodestone Wealth Management's CGCB Position: Q3 2026 in Review

Lodestone Wealth Management increased its Capital Group Core Bond ETF (CGCB) stake by 12% in Q3 2026, buying an estimated $260K and bringing the position to 93,309 shares worth $2.33M. The position accounts for 0.78% of the portfolio, ranked #36.

Lodestone Wealth Management first reported a position in CGCB in Q1 2024 and has held it in 11 quarters since. The position peaked at $2.4M in Q4 2025. 108 funds tracked by Wall St. Rank hold CGCB as of Q3 2026.

  • Lodestone Wealth Management held 93,309 shares of Capital Group Core Bond ETF worth $2.33M as of Q3 2026.
  • Lodestone Wealth Management bought 10,092 Capital Group Core Bond ETF shares in Q3 2026, an estimated $260K.
  • Capital Group Core Bond ETF made up 0.78% of Lodestone Wealth Management's portfolio in Q3 2026, its #36 holding.
  • Lodestone Wealth Management first reported a position in Capital Group Core Bond ETF in Q1 2024 and has held it in 11 quarters since.
  • Lodestone Wealth Management's Capital Group Core Bond ETF position peaked at $2.4M in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Capital Group Core Bond ETF as of Q3 2026.

Based on Lodestone Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.